Special Considerations for Therapy of Pediatric Atopic Dermatitis

Nanette B Silverberg1, Carola Durán-McKinster2

  • 1Department of Dermatology, Mt Sinai St Luke's-Roosevelt Hospital Center, 1090 Amsterdam Avenue, Suite 11B, New York, NY 10025, USA.

Insights

Pediatric atopic dermatitis, a common itchy rash, is usually diagnosed by age five. Management involves topical treatments, with systemic options available for severe cases.

Area of Science:

  • Pediatric Dermatology
  • Immunology

Background:

  • Atopic dermatitis is a prevalent skin condition in children, frequently leading to dermatology visits.
  • Diagnosis typically relies on characteristic rash patterns, location, and a history of atopy.
  • The majority of cases (85%) manifest by age five, with potential age-related comorbidities influencing disease progression.

Purpose of the Study:

  • To review the diagnostic criteria for pediatric atopic dermatitis.
  • To discuss current and alternative therapeutic strategies for managing childhood atopic dermatitis.
  • To highlight age-specific considerations and challenges in pediatric atopic dermatitis care.

Main Methods:

  • Literature review of diagnostic and management guidelines for pediatric atopic dermatitis.
  • Analysis of common treatment modalities, including topical corticosteroids and calcineurin inhibitors.
  • Examination of systemic therapies and their pediatric adaptations.

Main Results:

  • Recurrent, itchy rashes in specific locations, alongside a personal or family history of atopy, are key diagnostic indicators.
  • Topical corticosteroids are primary treatments, but concerns regarding "corticosteroidphobia" and side effects necessitate alternatives.
  • Topical calcineurin inhibitors offer a viable alternative, particularly for sensitive skin areas.

Conclusions:

  • Accurate diagnosis of pediatric atopic dermatitis relies on clinical presentation and history.
  • Therapeutic approaches should balance efficacy with safety, considering patient age and location of disease.
  • A comprehensive management plan, including topical and systemic options, is crucial for controlling childhood atopic dermatitis.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
434
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
606